REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Antigen, Epitope, Or Other Immunospecific Immunoeffector (e.g., Immunospecific Vaccine, Immunospecific Stimulator Of Cell-mediated Immunity, Immunospecific Tolerogen, Immunospecific Immunosuppressor, Etc.) > Bacterium Or Component Thereof Or Substance Produced By Said Bacterium (e.g., Legionella, Borrelia, Anaplasma, Shigella, Etc.) Bacterium Or Component Thereof Or Substance Produced By Said Bacterium (e.g., Legionella, Borrelia, Anaplasma, Shigella, Etc.)Bacterium Or Component Thereof Or Substance Produced By Said Bacterium (e.g., Legionella, Borrelia, Anaplasma, Shigella, Etc.) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.07/26/07 - 20070172495 - Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore Cell wall, cell surface and secreted protein nucleic acid molecules and polypeptides and fragments and variants thereof are disclosed in the current invention. In addition, cell wall, cell surface and secreted fusion proteins, antigenic peptides, and anti-cell wall, cell surface and secreted antibodies are encompassed. The invention also provides recombinant ... 07/05/07 - 20070154492 - Method for purifying polysaccharides This invention relates to improved methods for purifying polysaccharides from cellular components, such as a cell wall. The method relates to hydrolyzing and separating the polysaccharides, thereby resulting in purified polysaccharides useful for producing antigens, antibodies, and vaccines comprising the polysaccharides alone or conjugated to carrier molecules. This method is ... 06/21/07 - 20070141083 - Use of a single-cell protein material The present invention relates to the use of a single-cell protein material (SCP). The SCP material lowers the concentration of cholesterol in plasma, and triglycerides in the liver. SCP also induces a favourable change in the fatty acid pattern, and lowers the concentration of homocysteine in plasma. A preferable embodiment ... 06/14/07 - 20070134272 - Mannheimia haemolytica chimeric outer membrane protein pipe and leukotoxin epitopes as a vaccine or vaccine component against shipping fever Vaccine preparations for the prevention and treatment of bovine respiratory disease (BRD) and, in particular, its most severe form, termed “shipping fever”, are provided. The preparations comprise chimeric proteins comprising immunodominant epitopes of recombinant Mannheimia haemolytica outer membrane protein PlpE, and immunodominant epitopes of recombinant M. haemolytica leukotoxin. ... 06/07/07 - 20070128225 - Immunogenic sequences The application relates to nucleic acids which encode enzymes responsible for the production of the O-antigen of Francisella tularensis, and their use as or in the production of vaccines and in diagnosis. ... 05/24/07 - 20070116722 - Ovo vaccination of campylobacter in avian species The present invention provides a method of inducing an immune response against Campylobacter in an avian species, especially a domesticated avian species such as chicken, turkey, duck, goose and quail, by administering, in ovo, live cells of Campylobacter. ... 05/10/07 - 20070104736 - Non-toxic mutants of pathogenic gram-negative bacteria A method is provided for identifying, isolating, and producing htrB mutants of gram-negative bacterial pathogens. The method comprises mutating the htrB gene of a gram-negative bacterial pathogen so that there is a lack of a functional HtrB protein, resulting in a mutant that lacks one or more secondary acyl chains ... 05/10/07 - 20070104735 - Immune modulator Use of an immune modulator composition and/or pharmaceutical composition comprising a whole cell of a bacterium from the genera Rhodococcus, Gordonia, Nocardia, Dietzia, Tsukamurella and Nocardioides, for use in the manufacture of a medicament for the treatment of an autoimmune disease or autoimmune disorder, including certain vascular disorders. ... 05/03/07 - 20070098745 - Antagonistic properties of reef fish microflora The present invention provides methods for preventing biofilm formation on a surface. The present invention also relates to anti-biofilm forming agents, to methods of producing and using them, and to anti-fouling coatings produced therefrom. ... 05/03/07 - 20070098744 - Probiotic enterococci for improved immunity Compositions and methods for modulating immunity and vaccine efficacy in animals are disclosed. The compositions and methods utilize probiotic organisms, specifically probiotic Enterococcus strains, and are particularly applicable to felines. ... 03/22/07 - 20070065461 - Immunogenic capsule composition for use as a vaccine component against campylobacter jejuni An immunogenic composition, and method of using the composition, composed of a capsule polysaccharide polymer from one or more strains Campylobacter jejuni. The composition is either used alone or is conjugated to a carrier molecule, such as CRM197. An aspect of the invention is that the immunogenic composition induces an ... 03/22/07 - 20070065460 - Process for producing a capsular polysaccharide for use in conjugate vaccines A method for producing a polysaccharide and a conjugate vaccine including the polysaccharide produced according to the method. A characteristic step in the method is that the pH of the culture medium is kept at a constant value with base or acid until adjustment with respectively base or acid is ... 02/22/07 - 20070042004 - Methods of treating a bacterial infection using f. tularensis lipopolysaccharide The present invention relates to the ability of Francisella tularensis LVS lipopolysaccharide (LPS) to confer protection in a subject against a subsequent bacterial infection. Accordingly, the invention provides methods of treating and preventing bacterial infection in a subject by administering F. tularensis LPS to the subject. The invention also relates ... 02/22/07 - 20070042003 - Method of effecting a mammalian model of sepsis, severe sepsis, or septic shock A method of effecting a model of sepsis, severe sepsis, or septic shock in a mammalian subject which utilizes the step of introducing particulate or vesicle associated iNOS into the body of the mammalian subject. Prior to or during such introduction, an innate immune system activator may be introduced into ... 02/08/07 - 20070031456 - Leptospirosis culture process A process for the culture of Leptospires in a protein-free culture medium and without any fatty acid source in the culture medium, wherein a fatty acid source is fed continuously or intermittently. ... 02/01/07 - 20070026018 - Methods for treating, preventing and diagnosing helicobacter infection Compositions and methods for treating, preventing and diagnosing Helicobacter infection are disclosed. The methods use proteins and/or nucleic acids derived from Helicobacter cerdo, a new pathogen isolated from swine. ... 02/01/07 - 20070026017 - Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof The invention relates to Brachyspira pilosicoli 72 kDa outer-membrane protein (Bpmp-72) and its amino acid and neucleotide sequence. The invention also relates to the uses of these sequences in prophylactic (vaccination) and therapeutic treatment of infections with Brachyspira pilosicoli (internal spirochaetosis). ... 01/25/07 - 20070020291 - Vaccines for protection from bartonella infection and related methods of use Embodiments of the present invention generally comprise vaccines for substantially inhibiting or preventing infection from Bartonalla and related methods of vaccination. ... 01/18/07 - 20070014815 - Lawsonia vaccine and methods of use thereof The present invention provides improved vaccination methods for increased protection against ileitis. The methods provide for the vaccination of young animals, preferably piglets, between 10 and 26 days of age, vaccination of pregnant sows during the second or third stages of gestation, and a combination of these methods. Vaccination of ... 01/11/07 - 20070009553 - Bacterial strains of genus exiguobacterium, culture method and uses The invention concerns bacterial strains of genus Exiguobacterium. Said strains are thermoresistant, capable of growing on sugar and starch substrates and/or capable of producing metabolites such as L(+) lactate. The invention is useful for producing metabolites such as L(+) lactate. ... 12/28/06 - 20060292179 - Vaccines for immunization against helicobacter The invention relates to the immunisation of pigs against Candidatus Helicobacter suis using antigens of species related to Candidatus Helicobacter suis. ... 12/21/06 - 20060286126 - Sealing bacterial ghosts by means of bioaffinity interactions The invention relates to a method for preparing closed bacterial ghosts by way of specific interactions between partners of a bioaffinity binding pair, and to the bacterial ghosts which can be obtained in this way. Active compounds can be packed into the closed bacterial ghosts. The closed ghosts can be ... 12/14/06 - 20060280759 - Live and subunit vaccines Immunogenic compositions containing Francisella components or modified live strains of the Francisella species and their use in preventing or treating disease such as tularemia. ... 12/07/06 - 20060275324 - Probiotic system for aquaculture Probiotic bacterial strains are provided which inhibit or prevent growth or pathogenic bacteria in marine organisms. Also provided are methods of culturing marine organisms using the probiotic bacteria. ... 11/23/06 - 20060263389 - Methods and compositions to enhance immune responses via recall antigens The present invention provides a composition comprising a chimeric polypeptide comprising a recall antigen that reactivates memory T cells in a subject and a new antigen that activates naïve B cells in a subject and a composition comprising a nucleic acid encoding a chimeric polypeptide comprising a recall antigen that ... 11/16/06 - 20060257429 - Vaccine for periodontal disease The present invention relates to novel bacterial isolates identified by their 16S rRNA DNA, that cause periodontal disease in companion animals, and vaccines comprising such bacteria. Also provided are methods for treating and preventing periodontal disease and kits for detecting and treating periodontal disease kits for detecting and preventing periodontal ... 10/19/06 - 20060233835 - Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector The present invention comprises methods for enhancing the immunogenicity of a bacterial vaccine vector and an antigen by passaging the bacterial vaccine vector through an animal. ... 10/12/06 - 20060228379 - Novel microorganism pediococcus pentosaceus erom101, having immune enhancement, anticancer and antimicrobial activities The present invention relates to a novel Pediococcus genus microorganism and more particularly, Pediococcus pentosaceus EROM101 (KCCM-10517) originated from human intestines having immune enhancement, anticancer and antiviral activities and a use thereof. Due to its excellent immune enhancement, anticancer and antimicrobial activities by activating macrophages/spleen cells and inducing gut immunity, ... 10/12/06 - 20060228378 - Surface proteins of leptospira The invention relates to Leptospiral surface proteins, and the nucleic acid molecules which encode them. Various uses are described, including immunoprophylactic, diagnostic and therapeutic methods. ... 10/12/06 - 20060228377 - Gram-positive bacteria deprived of htra protease activity and their uses The invention concerns bacteria strains, obtained from gram-positive bacteria whereof the genome size is not more than 3.2 Mb, and wherein the HtrA surface protease is inactive. Said strains are useful for expressing exported proteins of interest. ... 08/31/06 - 20060193874 - Vaccines for proliferative ileitis and methods of making and using the same A proliferative ileitis vaccine comprising tissue culture grown Lawsonia intracellularis and methods of making said vaccines. Proliferative ileitis vaccines described include those containing whole L. intracellularis, extracts of L. intracellularis, protective immunogenic subunits of L. intracellularis, recombinant immunogens of L. intracellularis and naked DNA of L. intracellularis. The vaccines of ... 08/24/06 - 20060188524 - Canine vaccine for protection against ehrlichiosis The present invention provides a safe and effective vaccine composition which comprises: an effective immunizing amount of an inactivated Ehrlichia canis bacterin; a pharmacologically acceptable carrier; and an immunogenically stimulating amount of an adjuvant system consisting essentially of an antibody response inducing agent and a cell-mediated immunity response inducing agent. ... 08/24/06 - 20060188523 - Methods for diagnosing and treating chronic tonsillitis The invention relates to diagnostic methods, therapeutic methods and kits for diagnosing and treating chronic adenotonsillar tonsillitis and adenotonsillar hypertrophy as well as vaccines for preventing chronic adenotonsillar tonsillitis and adenotonsillar hypertrophy. ... 08/10/06 - 20060177469 - Non-toxic mucosal adjuvant A non-toxic mucosal adjuvant is provided which may be admixed with further antigens to provide a vaccine administrable to mucosal surfaces in organisms including man. Preferably, the non-toxic mucosal adjuvant is a detoxified mutant of a bacterial ADP-ribosylating toxin, optionally comprising one or more amino acid additions, deletions or substitutions. ... 07/27/06 - 20060165729 - Protein from photobacterium damselae and use thereof A derivative of a 55 kDa extracellular protein from Photobacterium damselae subsp. Piscicida is the basis for a vaccine against Photobacterium infection, and thereby protects fish from pasteurellosis. ... 07/27/06 - 20060165728 - Campylobacter glycans and glycopeptides Multiple strains and species of Campylobacter were found to share a common glycan moitie which is present in a plurality of surface-exposed glycoproteins. This glycan has the formula: GalNAc-a1,4-GalNAc-a1,4-[Glc-β1,3]GalNAc-a1,4-GalNAc-a1,4-GalNAc-a1,3-Bac, wherein Bac is 2,4-diacetamido-2,4,6-trideoxy-D-glucopyranose. This glycan and immunologically active fragments of it have use as vaccines against campylobacter infection in humans ... 07/20/06 - 20060159707 - Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived from Lawsonia intracellularis which encodes an immunogenic ... 07/13/06 - 20060153875 - Novel brachyspira hyodyseteriae vaccine The present invention relates to nucleic acid sequences encoding a 61 kD and a 20 kD Brachyspira hyodysenteriae lipoprotein and to parts of such nucleic acid sequences that encode an immunogenic fragment of such lipoproteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such ... 07/06/06 - 20060147470 - Cross-protective epitopes of moraxella catarrhalis and use thereof The present invention broadly relates to immunogenic compositions for administering to a host susceptible to Moraxella catarrhalis infection. More particularly, the invention is directed to the identification of cross-reactive epitope sequences of the CopB protein of Moraxella catarrhalis. ... 06/15/06 - 20060127416 - Hsp60 from arthrobacter The hsp60 gene from a strain of Arthrobacter has been isolated and sequenced. The encoded protein is believed to be highly immunogenic, especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens. ... 06/15/06 - 20060127415 - Drying process The present invention relates to a method of drying biological and other labile samples so that they can be preserved as a highly viscous liquid. The method involves the steps of preparing a preservation sample by dissolving/suspending an active agent in a solution of a stabilising agent, subjecting the preservation ... 05/25/06 - 20060110408 - Immunological combination compositions and methods Immununological compositions and methods for making and using them. The compositions contain at least one antigen and at least one lipoprotein and optionally an adjuvant. The lipoprotein can itself be antigenic or immunogenic. The antigen can be influenza HA and the lipoprotein a recombinantly expressed product having an OspA leader ... 04/27/06 - 20060088552 - Method for inhibiting cell death, cell death inhibitor, and remedy for disease caused by cell death containing the cell death inhibitor A method according to the present invention for inhibiting cell death includes administrating an anion channel-forming peptide to cells under lactacidosis. The anion channel-forming peptide forms an anion channel on a cell membrane artificially. A cell death inhibitor according to the present invention contains the anion channel-forming peptide. Some of ... 04/06/06 - 20060073167 - Vaccine for fish cold-water disease The present invention provides a vaccine for the bacterial cold-water disease in fish comprising inactivated cells of Flavobacterium psychrophilium in the logarithmic growth phase or components thereo ... 03/30/06 - 20060067949 - Immunization with porphyromonas gingivalis protects against heart disease The invention is directed to a method of preventing and treating a patient having a risk factor and/or a symptom of cardiovascular disease using an immunogenic composition comprising an immunogenically effective portion of Porphyromonas gingivalis in a pharmaceutically effective carrier substance, and a vaccine for same. ... 03/23/06 - 20060062807 - Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation Compositions comprising components prepared from Gram positive bacteria such as Gram positive facultative intra-cellular bacteria, for example mycobacteria, including extended freeze-dried killed Gram positive bacteria, their method of preparation and their use in humans and animals, for the prevention and/or the treatment of disorders comprising an immune dysregulation such as ... 12/15/05 - 20050276819 - Helicobacter pylori cai antigen This invention provides polynucleotides encoding Helicobacter pylori cytotoxin associated immunodominant antigen. The polynucleotides can be used as probes to identify the presence of complementary target nucleotide sequences. The invention also provides kits and vectors containing the polynucleotides of the invention. ... 12/01/05 - 20050266028 - Compositions and methods for modulating an immune response Composition and methods relating to a lipopolysaccharide isolated from Rhizobium galegae that enhances an immune response against an antigen yet does not induce a significant inflammatory response are described herein. ... 12/01/05 - 20050266027 - Live organism product A live organism product wherein the organisms are in a dormant state and are suspended in a liquid carrier which is substantially moisture-free. The carrier is comprised of oil. The carrier may also include an adsorbent. The product is stored and shipped in a plastic bag and is sprayed onto ... 11/24/05 - 20050260229 - Glycans of anaplasma marginale major surface protein 1a, pharmaceutical compositions and methods of use Glycans derived from the N-terminal repeated peptides of Anaplasma marginale major surface protein (MSP)1a are characterized. Pharmaceutical compositions including such epitopes, and methods useful to induce or enhance an immune response against infection by ehrlichial parasites of the species Anaplasma marginale, are provided. ... 10/13/05 - 20050226895 - Sequences from piscirickettsia salmonis The present invention relates to a fish vaccine. More specifically the invention relates to a vaccine to protect salmon against infection by Piscirickettsia salmonis. The invention is based on or derived from the nucleic acid or amino acid sequence of antigens from Piscirickettsia salmonis. Nucleic acid and/or amino acid sequences ... 10/13/05 - 20050226894 - Oral vaccination The invention relates to a drug for oral vaccination, the drug containing an antigenically active substance and a gastric acid reducing substance as a combination preparation for joint or separate, simultaneous or time shifted, oral application for vaccination. ... 10/06/05 - 20050220819 - Novel binding epitopes for helicobacter pylori and use thereof The present application describes a binding epitope to Helicobacter pylori, namely substances comprising the oligosaccharide sequence -Gal(Nac)r2$g(b)4Glc(A)q2(Nac)r3-, and the use thereof in pharmaceutical and nutritional compositions for the treatment of conditions due to the presence of Helicobacter pylori in a subject, e.g. gastritis, gastric ulcers, gastric adenocarcinoma, liver disease, pancreatic ... 09/15/05 - 20050202046 - Canine vaccine for protection against ehrlichiosis The present invention provides a safe and effective vaccine composition which comprises: an effective immunizing amount of an inactivated Ehrlichia canis bacterin; a pharmacologically acceptable carrier; and an immunogenically stimulating amount of an adjuvant system consisting essentially of an antibody response inducing agent and a cell-mediated immunity response inducing agent. ... 08/25/05 - 20050186226 - Method of treating diseases connected with immunity deficiency The invention is intended for treatment of diseases in accordance with immunity deficiency (HIV/AIDS diseases, oncological ailments and other). Purpose of it is reinforcement immunological reactivity organism. The method autohemovaccineimmunotherapy (hemovaccineimmunotherapy), diversified from prototype that that hemolyzed blood from sick person and inactivated at 56° C. for 30-40 min. is ... 08/11/05 - 20050175635 - Method and composition The present invention relates to a method for isolating and identifying specific immunogenic pathogen-specific peptides associated with stress proteins induced by the treatment of pathogens and pathogen-infected cells with stress inducing stimuli. The invention also relates to the use of the antigenic fragments derived from complexes thereof with heat shock ... 08/04/05 - 20050169941 - Use of amino-oxy functional groups in the preparation of protein-polysaccharide conjugate vaccines The invention relates to a process for preparing a conjugate comprising combining an amino-oxy homofunctional or heterofunctional reagent with an entity chosen from polysaccharides, oligosaccharides, carbohydrates, and carbohydrate-containing molecules containing at least one carbonyl group, to form a polysaccharide, oligosaccharide, carbohydrate, or carbohydrate-containing molecule functionalized via at least one oxime ... 07/28/05 - 20050163806 - Immune stimulating and controlling composition comprising bacterial chromosomal dna fragments and non-toxic lipopolysaccharides The present invention relates to immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysacchararides. The composition of the present invention can be industrially applied the effective materials for treating cancers and adjuvant. ... 07/21/05 - 20050158344 - Exoenzyme toxin of aeromonas salmonicida, and uses thereof A protein toxin named Aeromonas salmonicida exoenzyme T (AcxT), which belongs to the family of ADP-ribosylating toxins, is disclosed as is a Calcium (or other cation concentration) dependent promoter of A. salmonicida. Also disclosed are diagnostic, preventive, and therapeutic techniques, including the preparation of bacterin vaccines based on AexT for ... 07/07/05 - 20050147624 - Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue This invention relates to lipopolysaccharide-protein conjugate vaccines with appropriate presentation of conserved inner core oligosaccharide epitopes having improved immunogenic properties. These are based upon antigenic, detoxified bacterial lipopolysaccharides which optimally present an inner core oligosaccharide epitope following removal of at least a glycosidic phosphate of the lipid A region. These ... 06/23/05 - 20050136075 - Compositions and methods for bacterial immunity and secretion of proteins Attenuated strains of Gram negative bacteria carrying a mutation in one or more ysc genes or homologs are provided, as are methods of use for immunization against infection with a pathogenic strain and for delivery of a therapeutic agent. ... 06/16/05 - 20050129715 - Methods and compositions for immunotherapy of cancer The present invention includes compositions, methods and kits for inducing an immune response to a tumor and for treating cancer with a Listeria vaccine strain expressing an antigen fused to a truncated LLO protein. ... 06/16/05 - 20050129714 - Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells A vaccine based on live Arthrobacter cells is useful in preventing piscirickettsiosis in fish. ... 06/09/05 - 20050123566 - Immunomodulatory compounds and methods of use thereof The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and ... 06/09/05 - 20050123565 - System and method for transdermal vaccine delivery A system and method for transdermally delivering a vaccine to a patient including an iontophoresis delivery device having a donor electrode, a counter electrode, and electric circuitry for supplying iontophoresis energy to the electrodes, and a non-electroactive microprojection member having a plurality of stratum corneum-piercing microprojections extending therefrom. The vaccine ... 06/02/05 - 20050118197 - Polysaccharides of helicobacter pylori The invention is directed to immunogenic compositions comprising polysaccharides and polysaccharide-protein conjugates that are useful to induce or detect the production of antibodies specific for H. pylori. The invention is also directed to methods of purifying the H. pylori polysaccharides from bacteria. The polysaccharide may be incorporated into an immunogenic ... ### FreshPatents.com Support |